Methyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride

Catalog No.: 
ACXTZC758
CAS No.: 
5619-09-0
Molecular Formula: 
C12H15ClN2O2
Molecular Weight: 
254.72
Methyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$184.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride
IUPAC Namemethyl tryptophanate hydrochloride
MDL No.MFCD00066133
Molecular FormulaC12H15ClN2O2
Molecular Weight254.72
SMILESO=C(OC)C(N)CC1=CNC2=C1C=CC=C2.[H]Cl
InChI KeyXNFNGGQRDXFYMM-UHFFFAOYSA-N
Synonym5619-09-0 | DL-TRYPTOPHAN METHYL ESTER HYDROCHLORIDE | Methyl 2-amino-3-(1H-indol-3-yl)propanoate Hydrochloride | H-DL-Trp-OMe.HCl | DL-Tryptophan methyl ester HCl | H-DL-Trp-OMe HCl | MFCD00066133 | methyl 2-amino-3-(1H-indol-3-yl)propanoate;hydrochloride | d,l-tryptoph
CAS No.5619-09-0
PubChem CID2827264

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXTZC758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVROG230 route compound structure diagram
    ACVROG23054-12-6In Stock
  2. Then
  3. ACXTZC758 route product structure diagram
    ACXTZC7585619-09-0In Stock
Inquiry

2. ACXTZC758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKRBL783 route compound structure diagram
    ACKRBL783141215-69-2In Stock
  2. Then
  3. ACXTZC758 route product structure diagram
    ACXTZC7585619-09-0In Stock
Inquiry

3. ACXTZC758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXTZC758 route product structure diagram
    ACXTZC7585619-09-0In Stock
Inquiry

Comments (0)